SHIRE ORPHAN THERAPIES GMBH has a total of 26 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and Chile. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are UCB CELLTECH, GRYPHON THERAPEUTICS INC and CENTOCOR INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 2 | |
#3 | Chile | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | Taiwan | 2 | |
#9 | South Africa | 2 | |
#10 | China | 1 | |
#11 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Richter Uwe | 19 |
#2 | Hummel Gerd | 19 |
#3 | Reineke Ulrich | 19 |
#4 | Hellberg Mark R | 18 |
#5 | Osterkamp Frank | 18 |
#6 | Reimer Ulf | 17 |
#7 | Hawlisch Heiko | 16 |
#8 | Specker Edgar | 16 |
#9 | Simon Bernadett | 16 |
#10 | Knaute Tobias | 16 |
Publication | Filing date | Title |
---|---|---|
US9458198B1 | Cyclic peptide-based NPR-B agonists | |
CN105732767A | Novel NPR-B agonists |